Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic data for TH9507, a growth hormone-releasing factor analog, studied in HIV-infected participants. The update summariz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TH9507

Snippet

Sponsor: Theratechnologies | Conditions: HIV | Phase 1 | Status: COMPLETED